Literature DB >> 24605391

Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.

.   

Abstract

The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule four synthetic cannabinoids into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). The substances are: Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC); quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA); and N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA). This action is based on a finding by the Deputy Administrator that the placement of these synthetic cannabinoids and their optical, positional, and geometric isomers, salts and salts of isomers into schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities, and possess), or propose to handle these synthetic cannabinoids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24605391

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  16 in total

1.  Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.

Authors:  Brian F Thomas; Timothy W Lefever; Ricardo A Cortes; Megan Grabenauer; Alexander L Kovach; Anderson O Cox; Purvi R Patel; Gerald T Pollard; Julie A Marusich; Richard C Kevin; Thomas F Gamage; Jenny L Wiley
Journal:  J Pharmacol Exp Ther       Date:  2017-01-13       Impact factor: 4.030

2.  Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Behav Pharmacol       Date:  2015-08       Impact factor: 2.293

3.  Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.

Authors:  Kevin G Shanks; William Clark; George Behonick
Journal:  J Anal Toxicol       Date:  2016-01-10       Impact factor: 3.367

4.  Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model.

Authors:  Michael Hsin-Hung Chen; Aybike Dip; Mostafa Ahmed; Michael L Tan; Jeffrey P Walterscheid; Hua Sun; Ba-Bie Teng; Ashraf Mozayani
Journal:  J Cell Biochem       Date:  2015-11-24       Impact factor: 4.429

5.  Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22.

Authors:  George Behonick; Kevin G Shanks; Dennis J Firchau; Gagan Mathur; Charles F Lynch; Marcus Nashelsky; David J Jaskierny; Chady Meroueh
Journal:  J Anal Toxicol       Date:  2014-05-29       Impact factor: 3.367

Review 6.  Cannabinoid abuse and addiction: Clinical and preclinical findings.

Authors:  L V Panlilio; S R Goldberg; Z Justinova
Journal:  Clin Pharmacol Ther       Date:  2015-05-02       Impact factor: 6.875

7.  Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.

Authors:  Adebisi I Obafemi; Kurt Kleinschmidt; Collin Goto; Drew Fout
Journal:  J Med Toxicol       Date:  2015-12

8.  Synthetic cannabinoid use in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Patricia Acosta
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

9.  Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California.

Authors:  Karla D Wagner; Richard F Armenta; Alexis M Roth; Jane C Maxwell; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2014-05-27       Impact factor: 4.492

10.  Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.

Authors:  Joseph J Palamar; Mark K Su; Robert S Hoffman
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-17       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.